Jayoung Kim Selected Research

Jayoung Kim Research Topics

Disease

66	Neoplasms (Cancer) 05/2024 - 12/2002
25	Prostatic Neoplasms (Prostate Cancer) 03/2021 - 12/2002
24	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 09/2005
14	Interstitial Cystitis (Interstitial Cystitis, Chronic) 11/2023 - 08/2007
10	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2009
9	Inflammation (Inflammations) 02/2023 - 06/2011
8	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2003
6	Carcinoma (Carcinomatosis) 02/2021 - 10/2007
6	Brain Neoplasms (Brain Tumor) 11/2020 - 12/2016
5	Glioblastoma (Glioblastoma Multiforme) 03/2023 - 01/2019
5	Pain (Aches) 01/2022 - 01/2012
5	Lung Neoplasms (Lung Cancer) 12/2020 - 07/2013
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2020 - 08/2013
4	Ischemic Stroke 03/2020 - 01/2015
3	Infections 02/2024 - 01/2019
3	Thrombosis (Thrombus) 11/2021 - 01/2019
3	Triple Negative Breast Neoplasms 01/2021 - 01/2018
3	Macular Degeneration (Age-Related Maculopathy) 01/2020 - 01/2017
3	Urinary Bladder Diseases (Bladder Diseases) 01/2020 - 01/2018
3	Carcinogenesis 06/2018 - 10/2007
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2017 - 08/2014
3	Urologic Diseases (Urinary Tract Disease) 10/2016 - 06/2015
3	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 06/2016 - 08/2009
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2023 - 01/2022
2	Melanoma (Melanoma, Malignant) 10/2021 - 01/2018
2	Colonic Neoplasms (Colon Cancer) 02/2021 - 01/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2020 - 01/2019
2	Insulin Resistance 03/2020 - 12/2011
2	Liver Neoplasms (Liver Cancer) 01/2020 - 10/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 10/2017
2	Brain Ischemia (Cerebral Ischemia) 01/2020 - 08/2013
2	Choroidal Neovascularization 10/2019 - 10/2013
2	Macular Edema 10/2019 - 01/2017
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 09/2019 - 12/2017
2	Non-Muscle Invasive Bladder Neoplasms 06/2018 - 08/2015

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2004
22	Biomarkers (Surrogate Marker)IBA 02/2023 - 06/2003
10	CholesterolIBA 10/2022 - 02/2004
8	LipidsIBA 01/2019 - 02/2004
7	ErbB Receptors (EGF Receptor)IBA 11/2018 - 02/2007
6	LigandsIBA 05/2024 - 10/2007
6	PolymersIBA 03/2023 - 01/2014
6	Peptides (Polypeptides)IBA 02/2021 - 12/2002
6	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 12/2002
6	AndrogensIBA 01/2021 - 12/2002
5	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 07/2013
5	poly(beta-amino ester)IBA 11/2020 - 10/2017
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 01/2017
5	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2018
5	MicroRNAs (MicroRNA)IBA 06/2018 - 01/2013
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2014 - 12/2002
4	Messenger RNA (mRNA)IBA 05/2024 - 03/2009
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 06/2003
4	Ethylene Glycol (Monoethylene Glycol)IBA 11/2020 - 01/2016
4	Hormones (Hormone)IBA 01/2020 - 02/2007
4	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2005
4	Epidermal Growth Factor (EGF)IBA 11/2018 - 12/2002
3	RNA (Ribonucleic Acid)IBA 05/2024 - 01/2020
3	HydrogelsIBA 10/2023 - 01/2020
3	SolutionsIBA 01/2022 - 01/2020
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2020 - 06/2011
3	Celecoxib (Celebrex)FDA Link 12/2020 - 12/2017
3	Thymidine KinaseIBA 11/2020 - 01/2016
3	ProdrugsIBA 11/2020 - 01/2016
3	Verteporfin (Visudyne)FDA Link 01/2019 - 01/2018
3	Transcription Factors (Transcription Factor)IBA 06/2018 - 01/2013
3	EstersIBA 01/2018 - 01/2014
3	SialoglycoproteinsIBA 01/2012 - 08/2007
3	Tyrosine (L-Tyrosine)FDA Link 07/2009 - 04/2005
3	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 02/2009 - 09/2005
3	Heparin (Liquaemin)FDA LinkGeneric 02/2009 - 12/2002
2	AntibodiesIBA 05/2024 - 02/2024
2	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 01/2021
2	Keratin-13 (Keratin 13)IBA 01/2022 - 12/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 09/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021 - 07/2013
2	CytokinesIBA 10/2021 - 02/2004
2	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 01/2020
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2021 - 11/2015
2	Heterogeneous-Nuclear Ribonucleoprotein KIBA 01/2021 - 03/2009
2	Gemcitabine FDA Link 01/2021 - 10/2020
2	CateninsIBA 01/2021 - 06/2011
2	Ganciclovir (Cytovene)FDA LinkGeneric 11/2020 - 01/2016
2	Oxygen (Dioxygen)IBA 10/2020 - 08/2013
2	MelatoninIBA 01/2020 - 07/2016
2	Fc-saxatilinIBA 01/2020 - 01/2017
2	Small Interfering RNA (siRNA)IBA 11/2019 - 01/2019
2	octylonium (otilonium bromide)IBA 09/2019 - 12/2017
2	MicellesIBA 01/2019 - 01/2018
2	Dabigatran FDA Link 04/2018 - 10/2017
2	Warfarin (Coumadin)FDA LinkGeneric 04/2018 - 10/2017
2	EnzymesIBA 02/2018 - 05/2014

Therapy/Procedure

20	Therapeutics 05/2024 - 08/2012
13	Drug Therapy (Chemotherapy) 03/2023 - 03/2012
4	Immunotherapy 05/2024 - 01/2016
3	Injections 01/2022 - 07/2013
3	Capsule Endoscopes 10/2021 - 01/2019
3	Castration 12/2017 - 12/2011
2	Radiotherapy 01/2021 - 01/2019
2	Lasers (Laser) 10/2019 - 10/2013